Trastuzumab versus observation in women with early breast cancer and CK-19 mRNA-positive circulating tumor cells (CTCs): A pilot randomized phase II study.
暂无分享，去创建一个
S. Agelaki | G. Kallergi | V. Georgoulias | M. Perraki | D. Mavroudis | S. Apostolaki | A. Xyrafas | K. Kalbakis | V. Bozionelou | N. Androulakis